Sinocare(SZ:300298)2023-11-15 10:31Group 1: Market Overview - In 2021, the global adult diabetes patient population reached 537 million, with approximately 44.7% undiagnosed [2] - In China, the number of adult diabetes patients is 141 million, with an undiagnosed rate of 51.7% [2] - By 2045, the total number of diabetes patients is expected to rise to 783 million, indicating a significant increase in diabetes prevalence [2] Group 2: Product Development and Features - The company’s CGMS product "Sanofi Aikan" utilizes third-generation direct electronic transfer technology, achieving an i3 MARD value of 8.71% and an h3 MARD value of 7.45% [4] - The product features a minimally invasive design, allowing for easy operation without blood sampling, scanning, or calibration [4] - The company has established a sales and service network covering over 220,000 terminals in mainland China, supported by a team of nearly 200 healthcare professionals [4] Group 3: Future Directions and Innovations - Future product optimization will focus on improving monitoring accuracy, enhancing timeliness for alerts, reducing production costs, extending sensor lifespan, and improving user experience [5] - The company’s CGMS product received EU MDR certification on September 28, 2023, allowing entry into the European market [5] Group 4: Competitive Landscape - Current non-invasive blood glucose monitoring technologies are not expected to significantly impact the CGM industry, as CGM remains the recommended method for diabetes management [6] - The company’s CGMS product "Sanofi Aikan" was launched for online sales on April 30, 2023, and is gradually expanding into offline retail channels [6] Group 5: Financial Performance and Acquisitions - The acquisition of Trividia has led to significant synergies in product development, procurement, and market expansion, enhancing the company's production efficiency and quality management systems [5] - Trividia achieved profitability in Q3 2023, although it remains in an overall loss position for the first three quarters of the year [5]